Data gathered: November 14
Alternative Data for PureTech Health
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 6,000 | Sign up | Sign up | Sign up |
| Google Trends | 9 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 90 | Sign up | Sign up | Sign up |
| Twitter Mentions | 22 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
About PureTech Health
PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops and markets drugs for inflammatory, fibrotic and immune, intractable, lymphatic and gastrointestinal, neurological and neuropsychological cancers and other diseases in the United States. The company is headquartered in Boston, Massachusetts.
| Price | $21.93 |
| Target Price | Sign up |
| Volume | 7,660 |
| Market Cap | $547M |
| Year Range | $19.29 - $32.98 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Biotechnology |
In the news
Warning: PRTC is at high risk of performing badlyNovember 2 - Seeking Alpha |
|
PureTech Health Updates Share Capital and Development ProgressOctober 31 - TipRanks |
|
PureTech Health’s Director Transfers Shares to Alma MaterOctober 30 - TipRanks |
|
PureTech Health to Highlight Innovations at Key ConferencesOctober 29 - TipRanks |
|
 |
Head-To-Head Comparison: Revance Therapeutics (NASDAQ:RVNC) and PureTech Health (NASDAQ:PRTC)October 28 - ETF Daily News |
 |
PureTech Health plc (NASDAQ:PRTC) Short Interest UpdateOctober 27 - Biztoc.com |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q2 '24 | 140,000 | 19M | -19M | -21M | -32M | 0.000 |
| Q1 '24 | 140,000 | 19M | -19M | -21M | -32M | 0.000 |
| Q4 '23 | 0 | 0 | 0 | 0 | 0 | |
| Q3 '23 | 90,000 | 22M | -21M | -20M | -34M | 0.000 |
| Q2 '23 | 3.2M | 3.1M | 89,000 | -25M | -73M | 0.000 |
Insider Transactions View All
No recorded Insider transactions.
Similar companies
Read more about PureTech Health (PRTC) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, sentiment, webpage traffic, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter mentions, news mentions & customer reviews.
What is the Market Cap of PureTech Health?
The Market Cap of PureTech Health is $547M.
What is the current stock price of PureTech Health?
Currently, the price of one share of PureTech Health stock is $21.93.
How can I analyze the PRTC stock price chart for investment decisions?
The PRTC stock price chart above provides a comprehensive visual representation of PureTech Health's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling PureTech Health shares. Our platform offers an up-to-date PRTC stock price chart, along with technical data analysis and alternative data insights.
Does PRTC offer dividends to its shareholders?
As of our latest update, PureTech Health (PRTC) does not offer dividends to its shareholders. Investors interested in PureTech Health should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of PureTech Health?
Some of the similar stocks of PureTech Health are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.